- AvantGarde Capital Sequis Tower
- +62 21 505 77 007
- info@avantgarde-corp.com
Menu
Initial Public Offering (“IPO”) of PT Jayamas Medica Industri Tbk (“OneMed” or “OMED”) with Reg S International Offering listed on the Indonesian Stock Exchange with flotation of 15% new shares with market capitalization of c. IDR 6.0 trillion.
Founded in 2002 by dr. Jemmy Hartanto and headquartered in Surabaya, East Java, OneMed is the largest manufacturing and distribution company of medical equipment and supplies in Indonesia, covering 514 cities and 34 provinces. OneMed has the most comprehensive portfolio of medical equipment and supplies in the country, with over 3,200 SKUs and key products including syringes, medical gloves, antiseptics and disinfectants, and infusion sets. OneMed’s business is driven by its own brands under the flagship OneMed brand and has the largest distribution network nationwide serving 70% of all hospitals in Indonesia and 50% of all public clinics in Indonesia.
AvantGarde acted as the sole financial advisor to PT Jayamas Medica Industri Tbk in the IPO with Reg S International Offering and listing on the Indonesian Stock Exchange. AvantGarde assisted the Company in preparing and positioning the Company from pre-IPO stage.
Our value-add services comprised coordinating the whole workstream to ensure that the transaction is well executed in timely manner, arranging and advising the Company in the selection process of the Joint Global Coordinators, Joint Lead Underwriters and other supporting parties in the IPO.
AvantGarde played an instrumental role in building a solid investment thesis and robust business plan and financial model by having a close collaboration with the management. Throughout the project, we took a number of critical initiatives and creative and timely solutions and structure for the Company and the banks in order to ensure the successful and timely completion of the IPO. We also facilitated the entry of The Asian Development Bank (“ADB”), a blue-chip Asia Pacific multilateral bank, and negotiated with ADB as a key anchor investor taking a sizeable portion in the IPO.
